
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.
The CPRD bibliography is updated on a monthly basis (last updated 4 December 2019) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 3MB, 193 pages)
Export 45 results:
Author [ Title
Filters: Author is Dell'Aniello, S. [Clear All Filters]
“Antiepileptic drugs and the risk of ischaemic stroke and myocardial infarction: a population-based cohort study”, BMJ Open, vol. 5, p. e008365, 2015.
, “Association of Aripiprazole With the Risk for Psychiatric Hospitalization, Self-harm, or Suicide”, JAMA Psychiatry, 2019.
, “Association of Selective Serotonin Reuptake Inhibitors With the Risk for Spontaneous Intracranial Hemorrhage”, JAMA Neurol, vol. 74, pp. 173-180, 2017.
, “Bias from depletion of susceptibles: the example of hormone replacement therapy and the risk of venous thromboembolism”, Pharmacoepidemiol Drug Saf, vol. 26, pp. 554-560, 2017.
, “Cardiac glycosides and the risk of breast cancer in women with chronic heart failure and supraventricular arrhythmia”, Breast Cancer Res Treat, vol. 146, pp. 619-26, 2014.
, “Cardiac glycosides use and the risk of lung cancer: a nested case-control study”, BMC Cancer, vol. 14, p. 573, 2014.
, “Cardiovascular and cerebrovascular safety of testosterone replacement therapy among aging men with low testosterone levels: a cohort study.”, Am J Med, 2019.
, “Combination therapy with sulfonylureas and metformin and the prevention of death in type 2 diabetes: a nested case-control study”, Pharmacoepidemiol Drug Saf, vol. 19, pp. 335-42, 2010.
, “Comparative cardiovascular and hypoglycemic safety of glimepiride in type 2 diabetes: A population-based cohort study”, Diabetes Obes Metab, 2019.
, “Comparative effect of statins on the risk of incident Alzheimer disease”, Neurology, vol. 90, pp. e179-e187, 2018.
, “Comparative effectiveness and safety of LABA-LAMA versus LABA-ICS treatment of COPD in real world clinical practice”, Chest, 2019.
, “Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study”, Lancet Respir Med, vol. 6, pp. 855-862, 2018.
, “Comparative effectiveness of novel oral anticoagulants in UK patients with non-valvular atrial fibrillation and chronic kidney disease: a matched cohort study”, BMJ Open, vol. 8, p. e019638, 2018.
, , “The concurrent use of antithrombotic therapies and the risk of bleeding in patients with atrial fibrillation”, Thromb Haemost, vol. 109, pp. 431-9, 2013.
, “Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events”, Eur Respir J, vol. 49, 2017.
, “Concurrent use of statins and hormone therapy and risk of venous thromboembolism in postmenopausal women: a population-based case-control study”, Menopause, vol. 21, pp. 1023-6, 2014.
, “Concurrent use of tamoxifen with CYP2D6 inhibitors and the risk of breast cancer recurrence”, Breast Cancer Res Treat, vol. 126, pp. 695-703, 2011.
, “Degree of serotonin reuptake inhibition of antidepressants and ischemic risk: A cohort study”, Neurology, vol. 93, pp. e1010-e1020, 2019.
, “Dopamine agonist use and the risk of heart failure”, Pharmacoepidemiol Drug Saf, vol. 21, pp. 34-41, 2012.
, “The effect of statins on influenza-like illness morbidity and mortality”, Pharmacoepidemiol Drug Saf, vol. 26, pp. 63-70, 2017.
, “Extreme restriction design as a method for reducing confounding by indication in pharmacoepidemiologic research”, Pharmacoepidemiol Drug Saf, 2019.
, “Hormone replacement therapy and the risk of venous thromboembolism: a population-based study”, J Thromb Haemost, vol. 8, pp. 979-86, 2010.
, “Hormone replacement therapy use and the risk of stroke”, Maturitas, vol. 61, pp. 305-9, 2008.
, “Initiation of warfarin in patients with atrial fibrillation: early effects on ischaemic strokes”, Eur Heart J, vol. 35, pp. 1881-7, 2014.
, “Local estrogen therapy and risk of breast cancer recurrence among hormone-treated patients: a nested case-control study”, Breast Cancer Res Treat, vol. 135, pp. 603-9, 2012.
, “Long-Acting Bronchodilator Initiation in COPD and the Risk of Adverse Cardiopulmonary Events: A Population-Based Comparative Safety Study”, Chest, vol. 151, pp. 60-67, 2017.
, “Long-term effects of insulin glargine on the risk of breast cancer”, Diabetologia, vol. 54, pp. 2254-62, 2011.
, “Measuring persistence to hormonal therapy in patients with breast cancer: accounting for temporary treatment discontinuation”, Pharmacoepidemiol Drug Saf, vol. 23, pp. 882-9, 2014.
, “Metformin and the incidence of prostate cancer in patients with type 2 diabetes”, Cancer Epidemiol Biomarkers Prev, vol. 20, pp. 337-44, 2011.
, “A net clinical benefit analysis of warfarin and aspirin on stroke in patients with atrial fibrillation: a nested case-control study”, BMC Cardiovasc Disord, vol. 12, p. 49, 2012.
, “Pramipexole use and the risk of pneumonia”, BMC Neurol, vol. 12, p. 113, 2012.
, “Prescribing trends of attention-deficit hyperactivity disorder (ADHD) medications in UK primary care, 1995-2015”, Br J Clin Pharmacol, vol. 82, pp. 858-68, 2016.
, “Prevalent new-user cohort designs for comparative drug effect studies by time-conditional propensity scores”, Pharmacoepidemiol Drug Saf, vol. 26, pp. 459-468, 2017.
, “Risk of herpes zoster in patients prescribed inhaled corticosteroids: a cohort study”, BMC Pulm Med, vol. 11, p. 59, 2011.
, “Statins and Risk of Rheumatoid Arthritis: A Nested Case-Control Study”, Arthritis Rheumatol, vol. 68, pp. 2603-2611, 2016.
, , “Thiazolidinediones and the risk of incident strokes in patients with type 2 diabetes: a nested case-control study”, Pharmacoepidemiol Drug Saf, vol. 19, pp. 343-50, 2010.
, “Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study”, Bmj, vol. 340, p. c2519, 2010.
, “Trends in the prescription of novel oral anticoagulants in UK primary care”, Br J Clin Pharmacol, vol. 83, pp. 2096-2106, 2017.
, “The use of antidepressants and the risk of idiopathic pulmonary arterial hypertension”, Can J Cardiol, vol. 30, pp. 1633-9, 2014.
, “Use of tamoxifen and aromatase inhibitors in a large population-based cohort of women with breast cancer”, Br J Cancer, vol. 104, pp. 1558-63, 2011.
, “The Use of Telmisartan and the Incidence of Cancer”, Am J Hypertens, vol. 29, pp. 1358-1365, 2016.
, , “Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson's disease”, Br J Clin Pharmacol, vol. 82, pp. 461-72, 2016.
,